Post
· May 26, 2026
Source: Privacy Commissioner 27 May 2026, 05:01 The Privacy Commissioner has today released the findings of Phase 1 of his Inquiry into the December 2025 Manage My Health cyber incident...
Post
· May 26, 2026
Source: Privacy Commissioner 27 May 2026, 05:00 Privacy Commissioner Michael Webster has today released the results of Phase 1 of his Inquiry into the December 2025 Manage My Health cyber...
Post
· May 26, 2026
Source: Privacy Commissioner Updated 27 May 2026 Completion of Phase 1 of the Manage My Health Inquiry Privacy Commissioner Michael Webster has released the results of Phase 1 of his...
Post
· May 26, 2026
Source: Privacy Commissioner 27 May 2026, 05:00 Download a copy of the Executive summary: Inquiry into the cyber security breach affecting the Manage My Health Limited patient portal (opens to...
Post
· May 26, 2026
Source: New Zealand Police Please attribute to Senior Sergeant Michael Wickman, Auckland Police: Police have arrested one person as part of our enquiries into an incident yesterday. Police executed a...
Post
· May 26, 2026
Source: New Zealand Police Old Taupō Road is currently closed between Wiltsdown and Matanuku Roads, due to a single vehicle crash. The crash was reported about 7.10pm this evening. A...
Post
· May 26, 2026
Source: New Zealand Police One person has died following a crash on Pakuranga Road, Howick this afternoon. Emergency services responded to the crash between a car and a motorbike at...
Post
· May 26, 2026
Source: PHARMAC Pharmac is extending the consultation period on proposed changes to access criteria for type 2 diabetes medicines. In May, Pharmac released a proposal to amend the Special Authority...
Post
· May 26, 2026
Source: PHARMAC Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its upcoming meeting in June 2026. Applications Trabectedin (branded as Yondelis) for leiomyosarcoma and liposarcoma...
Post
· May 26, 2026
Source: PHARMAC Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its upcoming meeting in August 2026. Applications Mirvetuximab soravtansine-gynx (branded as Elahere) for epithelial ovarian, fallopian...